Cancer, genetics, “bad luck” and prevention through lifestyle: two years after their first study that tried to quantify the random mutations that accumulate during stem cell divisions in healthy cells and drive cancer in different [more]
A call to action to intervene on the many gaps in the care of patients with advanced or metastatic breast cancer (ABC/mBC), the European School of Oncology announced at the 15th St. Gallen International Breast Cancer [more]
Breast units staffed with specialist multidisciplinary teams deliver superior care and quality of life to women and men with breast cancer: this is the premise of the Manifesto on Breast Cancer Centres/Units that was discussed [more]
The Greek women sitting in the National and European parliament managed to find a prominent place in the political agenda for women with breast cancer through the establishment of the so-called “road map for treating [more]
This residential programme has been designed for medical and clinical oncologists, who wish to improve their skills or those who are preparing for the national board or ESMO exam. The programme will expose participants [more]
Although some of the principles underlying oncology practice are similar to those in other branches of medicine, subspecialisation has reduced the exposure of medical students and junior residents to oncological concepts and practice. New oncology [more]
This issue comes out as breast cancer specialists from around the world gather in Vienna for the 15th biannual St Gallen International Breast Cancer Conference, to discuss what we’ve learnt over the past two years about [more]
Brain tumours are tough to treat for so many reasons. Progress depends almost entirely on the steadfast commitment of doctors working within international networks. Peter McIntyre talked to some of them, to hear about their [more]
Clonal evolution and the ‘survival of the nastiest’ remain the chief obstacles to curing cancer. But what if we could find a way to use the principles of evolution to beat evolving cancers cells at [more]
How is it possible to help patients decide on the best treatment option for them, when they are scared, and when there is such uncertainty? Elżbieta Senkus, a specialist in breast and prostate cancers, talks [more]
With increasing numbers of cancer drugs being approved on shorter trials that involve fewer patients, getting accurate reports of adverse events and side effects after approval is increasingly important. Maria Delaney reports on efforts to [more]
Stimulating development of more and better paediatric cancer drugs will be key to making progress, particularly in some of the hardest-to-treat childhood cancers. Gilles Vassal, past-President of the European Society for Paediatric Oncology, outlines emerging [more]
Bradford Hesse and colleagues explore insights gained from over a decade of data gathered by the US National Cancer Institute to monitor changes in the communication environment regarding cancer-related information. This is an abridged version [more]